ZA997352B - Therapeutic agent for preventing and/or treating sepsis. - Google Patents

Therapeutic agent for preventing and/or treating sepsis.

Info

Publication number: ZA997352B
Authority: ZA; South Africa
Prior art keywords: preventing; therapeutic agent; sepsis; preventives; treating sepsis
Prior art date: 1998-03-19

Application number

ZA9907352A

Other languages

English (en)

Inventor

Tohru Tani

Hiroyuki Kondo

Original Assignee

Snow Brand Milk Products Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-19

Filing date

1999-11-26

Publication date

2000-05-29

1999-11-26 Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd

2000-05-29 Publication of ZA997352B publication Critical patent/ZA997352B/xx

Links

206010040047 Sepsis Diseases 0.000 title abstract 3
239000003814 drug Substances 0.000 title 1
229940124597 therapeutic agent Drugs 0.000 title 1
206010028980 Neoplasm Diseases 0.000 abstract 2
230000003449 preventive effect Effects 0.000 abstract 2
235000021476 total parenteral nutrition Nutrition 0.000 abstract 2
208000035473 Communicable disease Diseases 0.000 abstract 1
208000007746 Immunologic Deficiency Syndromes Diseases 0.000 abstract 1
108010094028 Prothrombin Proteins 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
238000002512 chemotherapy Methods 0.000 abstract 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 1
231100000433 cytotoxic Toxicity 0.000 abstract 1
230000001472 cytotoxic effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
238000001959 radiotherapy Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Water Treatment By Sorption (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA9907352A 1998-03-19 1999-11-26 Therapeutic agent for preventing and/or treating sepsis. ZA997352B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP10070914A JPH11269091A (ja)	1998-03-19	1998-03-19	敗血症予防及び／又は治療剤

Publications (1)

Publication Number	Publication Date
ZA997352B true ZA997352B (en)	2000-05-29

Family

ID=13445266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9907352A ZA997352B (en)	1998-03-19	1999-11-26	Therapeutic agent for preventing and/or treating sepsis.

Country Status (13)

Country	Link
US (1)	US20060251615A1 (de)
EP (1)	EP0982037B1 (de)
JP (1)	JPH11269091A (de)
KR (1)	KR100572044B1 (de)
AT (1)	ATE363913T1 (de)
AU (1)	AU753198B2 (de)
CA (1)	CA2288881A1 (de)
DE (1)	DE69936248T2 (de)
DK (1)	DK0982037T3 (de)
ES (1)	ES2288014T3 (de)
TW (1)	TW518229B (de)
WO (1)	WO1999047155A1 (de)
ZA (1)	ZA997352B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4006058B2 (ja)	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
ES2274567T3 (es)	1997-03-14	2007-05-16	Daiichi Pharmaceutical Co., Ltd.	Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ232813A (en) *	1989-03-10	1992-08-26	Snow Brand Milk Products Co Ltd	Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
KR100271087B1 (en) *	1992-07-16	2000-11-01	Snow Brand Milk Products Co Ltd	Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
EP0653211B1 (de) *	1992-07-16	2001-10-17	Snow Brand Milk Products Co., Ltd.	Normalisierer der blutkoagulation enthaltend tcf-ii als aktiven bestandteil

1998
- 1998-03-19 JP JP10070914A patent/JPH11269091A/ja active Pending
1999
- 1999-03-19 AU AU28536/99A patent/AU753198B2/en not_active Ceased
- 1999-03-19 WO PCT/JP1999/001373 patent/WO1999047155A1/ja not_active Ceased
- 1999-03-19 CA CA002288881A patent/CA2288881A1/en not_active Abandoned
- 1999-03-19 ES ES99909244T patent/ES2288014T3/es not_active Expired - Lifetime
- 1999-03-19 DK DK99909244T patent/DK0982037T3/da active
- 1999-03-19 AT AT99909244T patent/ATE363913T1/de not_active IP Right Cessation
- 1999-03-19 DE DE69936248T patent/DE69936248T2/de not_active Expired - Fee Related
- 1999-03-19 TW TW088104280A patent/TW518229B/zh not_active IP Right Cessation
- 1999-03-19 KR KR1019997010648A patent/KR100572044B1/ko not_active Expired - Fee Related
- 1999-03-19 EP EP99909244A patent/EP0982037B1/de not_active Expired - Lifetime
- 1999-11-26 ZA ZA9907352A patent/ZA997352B/xx unknown
2005
- 2005-07-21 US US11/186,638 patent/US20060251615A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0982037A4 (de)	2004-10-13
ES2288014T3 (es)	2007-12-16
KR100572044B1 (ko)	2006-04-17
AU753198B2 (en)	2002-10-10
ATE363913T1 (de)	2007-06-15
EP0982037B1 (de)	2007-06-06
JPH11269091A (ja)	1999-10-05
DK0982037T3 (da)	2007-10-08
EP0982037A1 (de)	2000-03-01
WO1999047155A1 (fr)	1999-09-23
TW518229B (en)	2003-01-21
DE69936248D1 (de)	2007-07-19
CA2288881A1 (en)	1999-09-23
DE69936248T2 (de)	2008-01-31
KR20010012687A (ko)	2001-02-26
US20060251615A1 (en)	2006-11-09
AU2853699A (en)	1999-10-11

Similar Documents

Publication	Publication Date	Title
MY140398A (en)	2009-12-31	4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
AP1553A (en)	2006-01-18	Tricyclic inhibitors of poly (ADP-Ribose) polymerases.
AU747599C (en)	2003-06-05	Antitumor agents
MY155218A (en)	2015-09-30	Small molecules useful in the treatment of inflammatory disease
WO1999054326A8 (de)	1999-12-29	Dihydropyrimidine
MXPA03007837A (es)	2004-03-16	Composiciones para suministrar bisfosfonatos.
NO20013402D0 (no)	2001-07-09	Fremgangsmåter for behandling av ovarialcancer, poly(fosfoester)preparater, og bionedbrytbare gjenstander for detsamme
WO2003049702A8 (en)	2004-08-19	Vanilloid receptor ligands and their use in treatments
BG101118A (en)	1998-04-30	Therapeutical compounds
BG104436A (en)	2000-12-29	The administration of macrolides for the treatment of cancer and macular degeneration
ZA200306541B (en)	2004-11-22	Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin.
DK0862634T4 (da)	2006-05-08	Farmaceutisk præparat mod papillomavirustumorer og -infektioner
TNSN03060A1 (en)	2005-12-23	A combination comprising combretastatin and anticancer agents
AU1044500A (en)	2000-05-22	Imidazonaphthyridines
PL342614A1 (en)	2001-06-18	Anticarcinogenic drugs
ATE265455T1 (de)	2004-05-15	Tetrahydropyridoverbindungen
TR199801732T2 (xx)	1998-12-21	Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
EP0281070A3 (de)	1989-11-23	Pharmazeutische Zusammensetzung für die Krebsbehandlung
EP1208840A3 (de)	2003-05-21	Zusammensetzung zur Behandlung von Tumoren oder Krebs, welche Fluorouracil und ein Methylol Übertragungsmittel enthält
ZA997352B (en)	2000-05-29	Therapeutic agent for preventing and/or treating sepsis.
WO2002078690A3 (en)	2002-11-21	Taxoid anti-tumor agents and pharmaceutical compositions thereof
WO2000001729A3 (en)	2000-02-10	Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome
ZA982068B (en)	1998-09-16	Agent for preventing and/or treating cachexia
YU46302A (sh)	2005-06-10	Supstituisani piroli
WO2002076393A3 (en)	2003-04-03	Antiagionecic, antitumor, chemopreventative agents